![Upendra K. Marathi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Upendra K.
Marathi is the founder of 7 Hills Pharma LLC, serving as Chief Executive Officer & Director since 2015.
Former positions include Managing Director at MediGen Group LLC, Senior Vice President at PLx Pharma, Inc., Principal at BCM Technologies, Inc., and Faculty Member at William Marsh Rice University.
Education includes an MBA from William Marsh Rice University and a doctorate from Loyola University of Chicago.
| Società | Posizione | Inizio |
|---|---|---|
7 Hills Pharma LLC
 7 Hills Pharma LLC Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer treatment | Fondatore | - |
| Società | Posizione | Fine |
|---|---|---|
BCM Technologies, Inc.
 BCM Technologies, Inc. Investment ManagersFinance BCM Technologies invests in companies located in the United States. The firm focuses on sectors such as medicine, pharmaceutical and life science. It participates in seed and early stage capital transactions. It acts as a lead investor and also makes co-investments. | Corporate Officer/Principal | - |
PLx Pharma, Inc. /Old/
 PLx Pharma, Inc. /Old/ Pharmaceuticals: OtherHealth Technology Develops formulations of non steroidal anti-inflammatory drugs | Corporate Officer/Principal | - |
Rice University
 Rice University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
MediGen Group LLC
 MediGen Group LLC Investment ManagersFinance MediGen Group provides seed and early-stage capital to new life sciences companies. The firm may fund proof-of-concept experiments and deal conceptualization. Companies should have large growing markets and strong intellectual property. They should also have defined regulatory paths to accelerate product development and mitigate FDA approval risk. MediGen seeks investments in companies with a clear path to monetization with substantial short-term value-creating milestones that allow for multiple exit opportunities and hedges against developmental setbacks | Investitore di Private Equity | - |
Attive
Inattive
Società nel listino
Aziende private
| Aziende private | 6 |
|---|---|
PLx Pharma, Inc. /Old/
PLx Pharma, Inc. /Old/ Pharmaceuticals: OtherHealth Technology Develops formulations of non steroidal anti-inflammatory drugs | Health Technology |
BCM Technologies, Inc.
BCM Technologies, Inc. Investment ManagersFinance BCM Technologies invests in companies located in the United States. The firm focuses on sectors such as medicine, pharmaceutical and life science. It participates in seed and early stage capital transactions. It acts as a lead investor and also makes co-investments. | Finance |
Rice University
Rice University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Loyola University of Chicago
 Loyola University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MediGen Group LLC
MediGen Group LLC Investment ManagersFinance MediGen Group provides seed and early-stage capital to new life sciences companies. The firm may fund proof-of-concept experiments and deal conceptualization. Companies should have large growing markets and strong intellectual property. They should also have defined regulatory paths to accelerate product development and mitigate FDA approval risk. MediGen seeks investments in companies with a clear path to monetization with substantial short-term value-creating milestones that allow for multiple exit opportunities and hedges against developmental setbacks | Finance |
7 Hills Pharma LLC
7 Hills Pharma LLC Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer treatment | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
